We show that minute amounts of cancer DNA can be detected in blood more sensitively than ever before.
Academic rigor, journalistic flair
Articles on Cancer treatment
Displaying 21 - 40 of 84 articles
Following the success of the cervical cancer vaccine, new work on links between viruses and cancers raises promising possibilities.
Our team found that chemotherapy can be made more successful by treating nearby ‘normal’ cells with protein-blocking drugs in lymphoma and leukemia.
Late detection of breast cancer means treatment is often drastic and frightening for patients.
Low-dose CT scans can detect lung cancer in smokers and former smokers at an early and sometimes treatable stage. Why are so few smokers and former smokers getting them?
Cilia appear on nearly every cell in the body and their presence (or lack of) can drastically change our health.
Pancreatic cancer currently has one of the least optimistic prognosis, with just 5% of patients surviving five years after diagnosis. A recent study opens a door to hope.
A cancer diagnosis is one of the scariest of all. The pain and fear are worsened by a confusing landscape of bills, opaque billing systems and changing insurance rules, rates and reimbursements.
Cancer treatment could be revolutionised by the discovery of the origin cells which divide first.
People across the country show their support for breast cancer patients and survivors by wearing pink and raising money each October. A recent study of patients suggests ways to help all year.
Academic research brings people close together as they collaborate on shared goals and projects that often last decades. Saying goodbye to a collaborator can be as hard as saying goodbye to family.
Snake oil salesman have been touting black salve for generations. But the evidence doesn’t stack up.
Pediatric cancer is one of the cruelest of diseases, and caregivers develop special skills to help their patients. Research shows that caregivers for adults could learn some things from them.
A cancer is in remission when it can no longer be detected. But we only say it’s cured when it hasn’t come back for a certain time – and that differs for different cancers.
Immunotherapy drugs work by increasing the patient’s own immune response. The most successful examples of immunotherapies are drugs that act as antibodies, of which Keytruda is one.
Great strides have been made in cancer medicine over decades, but it’s important not to forget the growing role that kindness and empathy play in good care.
Some argue the current system of subsidising drugs in Australia needs changing to accommodate new cancer therapies. But two recent drug listings show the current system is working perfectly well.
Why hasn’t there been an improvement in survival in the last 30 years for patients with brain cancers?
Leukaemia used to be a death sentence. Now, the survival rate for the most common form in children is 85%. We can apply similar strategies to how we approach childhood brain cancer.
Researchers have long been looking for clues into how to treat triple negative breast cancer. Could fighter blood cells that infiltrate the tumor provide insight?
Top contributors
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Professorial Research Fellow. School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide
-
NHMRC Senior Research Fellow, Centre for Cancer Biology, University of South Australia
-
University Distinguished Professor of Marketing, Mays Business School; Senior Fellow, Institute for Healthcare Improvement, Texas A&M University
-
Professor of Exercise Medicine, Edith Cowan University
-
Veronique Chachay is a Friend of The Conversation.
Research & Teaching Academic, The University of Queensland
-
Professor of Health Economics, Deputy Director of CHERE, University of Technology Sydney
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Behavioural Ecology, UCL
-
Chancellor's Professor of Medicine, Liberal Arts, and Philanthropy, Indiana University
-
Lecturer in Robotics, University of Bristol
-
Associate Professor, Cornell University
-
Professor of Experimental Cancer Therapeutics, Institute of Cancer Research, London
-
Lecturer in Speech Pathology, The University of Queensland
-
Dean, Graduate Research, University of Canberra
